Live feed
Filing
SC 13G/A
SC 13G/A0000902219-24-000469·Denali Therapeutics Inc.
Schedule 13G ownership disclosure
Denali Therapeutics Inc
Security class unavailable · CUSIP: 24823R105
Event date: 2024-09-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 10,727,450
- Percent of class
- 7.4900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902219-24-000469
- Form type
- SC 13G/A
- Filer
- Denali Therapeutics Inc.
- CIK
- CIK 1714899
- Filed
- Nov 08, 2024
- Reporting period
- Sep 30, 2024
- Description
- Schedule 13G beneficial ownership